Our Businesses

Developing Self-Operated Industrial and OEM Products

Based on the existing varieties, brands, channels and marketing advantages, Nuelmed conducts targeted development of self-operated industrial and OEM products by virtue of big data accumulated by the Company's "hundred-billion-level" supply chain service platform, and then distributes pharmaceuticals to terminal or C-end consumers through its full-channel sales network.

Western Medicine Industry

In terms of pharmaceutical production, the Company's subsidiary Beijing Jingfeng Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jingfeng Pharmaceutical") currently holds over 300 approved drug registration numbers, with products covering more than 10 dosage forms and over 170 products in production.The main product series include antidiabetic drugs, topical medications, anti-infective and respiratory drugs, cardiovascular drugs, and nervous system drugs, featuring star products such as the "Metformin" series and Compound Clotrimazole Cream. In terms of drug research and development, Jingfeng Pharmaceutical focuses on four major therapeutic areas: antidiabetic, topical, cardiovascular and cerebrovascular, and anti-infective drugs. Currently, 12 drug varieties have passed consistency evaluation, with new products under development including 11 active pharmaceutical ingredients (APIs) and 25 formulations. In the future, Jingfeng Pharmaceutical will establish a dual-track model for its chronic disease management (Type II Diabetes and Topical Medications), offering a holistic health service system for chronic disease patients.